Skip to main content

Table 5 Number of patients measured per omics for each cancer type. Total: Number of patients measured for at least one omics (of which those having been measured for the three omics); proportion of partial data; Exp+Met: Patients measured for expression and methylation only; Exp+miRNA: Patients measured for expression and miRNA only; Met+miRNA: Patients measured for methylation and miRNA only; Exp: Patients measured for expression only; Met: Patients measured for methylation only; miRNA: Patients measured for miRNA only

From: Consensus clustering applied to multi-omics disease subtyping

Cancer

Total (multi-omic)

% partial data

Exp+ Met

Exp+ miRNA

Met+ miRNA

Exp

Met

miRNA

AML

197 (170)

13.71

0

3

15

0

9

0

BIC

1096 (621)

43.34

159

132

2

181

1

0

COAD

303 (220)

27.39

57

0

0

8

18

0

GBM

578 (274)

52.60

4

245

3

5

4

43

KIRC

534 (183)

65.73

135

71

0

144

1

0

LIHC

377 (367)

2.65

4

0

5

0

1

0

LUSC

501 (341)

31.94

29

1

0

130

0

0

OV

591 (287)

51.44

7

0

166

9

122

0

SARC

261 (257)

1.53

2

0

2

0

0

0

SKCM

368 (351)

4.62

16

1

0

0

0

0